Hengruiyuan
Songjiang
About Hengruiyuan
Hengruiyuan is a biopharmaceutical company that develops medications based on immune cell treatment technologies for solid tumors.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 501 – 1,000
- Total funding: $42.8M
- Funding stage: Late Stage Venture
- Last round: Series C (Jan 2024)
- Website: shhryz.com
- Phone: 021-61049928
Industries & Categories
Biopharma, Biotechnology, Medical, Product Research
Canonical: https://fsome.com/organization/hengruiyuan-2841 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.